Skip to main content

Table 1 Characteristics of the patients at baseline

From: Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure

Characteristic

Pre-op levosimendan (n = 40)

No-levosimendan (n = 22)

Total (n = 62)

P value

Age—yr

57.3 (51.3–62.9)

57.2 (52.6–65.1)

57.2 (51.7–63.1)

0.79

Male sex

33 (82.5)

22 (100)

55 (88.7)

0.04

HF etiology

0.16

 ICMP

18 (45)

14 (63.6)

32 (51.6)

 DCM

21 (52.5)

7 (31.8)

28 (45.1)

NYHA class

0.003

 3B

2 (5)

8 (36.4)

10 (16.1)

 4

38 (95)

14 (63.6)

52 (83.9)

INTERMACS score

0.08

 2

17 (42.5)

6 (27.3)

23 (37.1)

 3

9 (22.5)

2 (9.1)

11 (17.7)

 4

14 (35)

14 (63.6)

28 (45.2)

Diabetes mellitus

17 (42.5)

9 (40.9)

26 (41.9)

0.9

Chronic kidney disease

13 (32.5)

11 (50)

24 (38.7)

0.17

Creatinine—mg/dL

0.98 (0.73–1.39)

1.3 (1.09–1.6)

1.15 (0.83–1.44)

0.01

MDRD—mL/min/1.73 m2

78.4 (55.9–105.9)

61.5 (47.5–76.0)

68.2 (52.4–97.9)

0.029

Bilirubin—mg/dL

0.8 (0.56–1.17)

0.86 (0.68–1.7)

0.8 (0.62–1.24)

0.27

Albumin—g/dL

3.7 (3.4–4.0)

4 (3.6–4.4)

3.8 (3.4–4.1)

0.024

Echocardiography

EF—%

15 (10–20)

17.5 (12.2–25.0)

15 (10–20.5)

0.27

MR—above moderate

18 (45)

7 (31.8)

25 (40.3)

0.31

TR—above moderate

4 (10)

3 (13.6)

7 (11.3)

0.69

Enlarged RV

18 (40)

7 (31.8)

25 (40.3)

0.31

RV function

0.15

 Normal

6 (15)

8 (36.4)

14 (22.6)

 Mild reduction

13 (32.5)

5 (22.7)

18 (29)

 Moderate–severe reduction

21 (52.5)

9 (40.9)

30 (48.4)

SPAP—mmHg

55 (50.25–60)

53 (41–60)

54.5 (48.75–60)

0.55

Right heart catheterization

 CO—l/min

2.93 (2.48–3.67)

3.19 (2.53–3.69)

2.98 (2.5–3.68)

0.48

 PCWP—mmHg

28 (23.75–31.5)

23.5 (18.75–30.25)

27 (21.25–31)

0.047

 mPA—mmHg

41.5 (34.5–46)

33 (30.5–46.5)

40 (33–46)

0.32

 mRA—mmHg

10 (7–13)

8 (4–16.5)

9.5 (6–13)

0.56

 RA/PCWP

0.37 (0.27–0.47)

0.37 (0.25–0.46)

0.37 (0.25–0.46)

0.98

 PAPi

3.75 (2.79–5.21)

4.75 (3.15–12)

4.5 (2.8–10.7)

0.21

 PVR—wood units

3.17 (2.42–4.87)

4.02 (2.19–6.13)

3.41 (2.4–5.16)

0.43

  1. Data are presented as median (Interquartile range) or number (%)
  2. ICMP, ischemic cardiomyopathy; IDC, idiopathic dilated cardiomyopathy; SPAP, systolic pulmonary artery pressure; CO, cardiac output; PCWP, pulmonary capillary wedge pressure; mPA/RA, mean pulmonary artery/right atrium pressure; PAPi, pulmonary artery pulsatility index; PVR, pulmonary vascular resistance